|
Real-time Estimate
Cboe BZX
21:22:00 29/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 174.16 USD | +2.74% |
|
+0.63% | +89.56% |
| 09:00pm | European stocks rally after ECB and Fed holds | AN |
| 10-28 | AstraZeneca PLC : Deutsche Bank remains Neutral | ZD |
Company Valuation: AstraZeneca PLC
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 182,034 | 209,442 | 209,268 | 203,171 | 287,813 | 263,524 | - | - |
| Change | - | 15.06% | -0.08% | -2.91% | 41.66% | -8.44% | - | - |
| Enterprise Value (EV) 1 | 206,417 | 232,365 | 231,778 | 227,741 | 311,187 | 284,194 | 276,755 | 268,260 |
| Change | - | 12.57% | -0.25% | -1.74% | 36.64% | -8.67% | -2.62% | -3.07% |
| P/E | 1,469x | 64.1x | 35.4x | 29.1x | 28.4x | 22.2x | 19x | 16.8x |
| PBR | 4.24x | 5.65x | 5.39x | 5.02x | 5.96x | 4.87x | 4.23x | 3.64x |
| PEG | - | 0x | 0.4x | 1.6x | 0.6x | 1.3x | 1.1x | 1.3x |
| Capitalization / Revenue | 4.87x | 4.72x | 4.57x | 3.76x | 4.9x | 4.16x | 3.91x | 3.69x |
| EV / Revenue | 5.52x | 5.24x | 5.06x | 4.21x | 5.3x | 4.49x | 4.11x | 3.75x |
| EV / EBITDA | 27.2x | 25.2x | 17.1x | 13.6x | 16x | 12.8x | 11.3x | 9.92x |
| EV / EBIT | 20.8x | 17.4x | 15.9x | 13.5x | 16.8x | 13.5x | 11.9x | 10.5x |
| EV / FCF | 42.4x | 26.7x | 25.8x | 22.9x | 26.5x | 28.6x | 21.5x | 18.1x |
| FCF Yield | 2.36% | 3.75% | 3.88% | 4.36% | 3.78% | 3.49% | 4.65% | 5.51% |
| Dividend per Share 2 | 2.87 | 2.9 | 2.9 | 3.1 | 3.2 | 3.343 | 3.545 | 3.656 |
| Rate of return | 2.44% | 2.15% | 2.15% | 2.37% | 1.72% | 1.97% | 2.09% | 2.15% |
| EPS 2 | 0.08 | 2.11 | 3.81 | 4.5 | 6.54 | 7.649 | 8.933 | 10.09 |
| Distribution rate | 3,588% | 137% | 76.1% | 68.9% | 48.9% | 43.7% | 39.7% | 36.2% |
| Net sales 1 | 37,417 | 44,351 | 45,811 | 54,073 | 58,739 | 63,323 | 67,369 | 71,482 |
| EBITDA 1 | 7,586 | 9,237 | 13,580 | 16,691 | 19,476 | 22,167 | 24,474 | 27,047 |
| EBIT 1 | 9,928 | 13,350 | 14,534 | 16,928 | 18,478 | 21,071 | 23,286 | 25,612 |
| Net income 1 | 112 | 3,288 | 5,961 | 7,035 | 10,225 | 11,747 | 13,633 | 15,299 |
| Net Debt 1 | 24,383 | 22,923 | 22,510 | 24,570 | 23,374 | 20,670 | 13,231 | 4,735 |
| Reference price 2 | 117.51 | 135.16 | 135.02 | 131.05 | 185.60 | 169.90 | 169.90 | 169.90 |
| Nbr of stocks (in thousands) | 1,549,159 | 1,549,528 | 1,549,926 | 1,550,317 | 1,550,726 | 1,551,024 | - | - |
| Announcement Date | 10/02/22 | 09/02/23 | 08/02/24 | 06/02/25 | 10/02/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 37.84x | 13.27x | 28.43x | 0.53% | 1,148B | |
| 39.67x | 6.67x | 18.75x | 1.97% | 652B | |
| 37.4x | 8.39x | 17.35x | 2.4% | 505B | |
| 21.45x | 5.21x | 12.93x | 2.51% | 384B | |
| 102.73x | 5.76x | 24.72x | 2.42% | 348B | |
| 21.89x | 5.76x | 13.88x | 2.85% | 294B | |
| 22.21x | 4.49x | 12.82x | 1.97% | 264B | |
| 28.66x | 7.33x | 13.12x | 2.23% | 244B | |
| -45.79x | 7.11x | 27.55x | 2.07% | 197B | |
| Average | 29.56x | 7.11x | 18.84x | 2.11% | 448.57B | |
| Weighted average by Cap. | 35.29x | 8.40x | 20.64x | 1.79% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- AZN Stock
- AZN Stock
- Valuation AstraZeneca PLC
Select your edition
All financial news and data tailored to specific country editions
